Ravenstone Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$407K |
| 2 |
Sundial Growers
SNDL
|
+$751 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.59M |
| 2 |
Nike
NKE
|
+$1.27M |
| 3 |
Microsoft
MSFT
|
+$756K |
| 4 |
Fortinet
FTNT
|
+$700K |
| 5 |
American Tower
AMT
|
+$518K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Healthcare | 25.28% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 10.72% |
| 5 | Communication Services | 8.9% |
Similar funds
Ravenstone Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Ravenstone Capital Management held 38 positions worth $124M, up 1.6% from $122M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Ravenstone Capital Management withdrew a net $6.95M in Q1 2023, closing 3 positions and reducing 20 holdings. Its most notable exit was CRISPR Therapeutics, an estimated $32.5K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ravenstone Capital Management opened a new position in Sundial Growers worth $614.
- Ravenstone Capital Management's largest Q1 2023 buy was Sundial Growers: 383 shares worth $614.
- Ravenstone Capital Management added most to Canadian Pacific Kansas City in Q1 2023, an estimated $407K increase.
- Ravenstone Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $1.59M.
- Ravenstone Capital Management fully exited CRISPR Therapeutics in Q1 2023, selling an estimated $32.5K.
- Ravenstone Capital Management's ten largest holdings make up 64% of its $124M portfolio in Q1 2023.
- Ravenstone Capital Management opened 1 new position and closed 3 in Q1 2023.
- Ravenstone Capital Management's portfolio value rose 1.6% quarter-over-quarter to $124M.
Based on Ravenstone Capital Management's 13F filing for Q1 2023, filed 26 Jun 2026.